Eventide Asset Management, LLC Verona Pharma PLC Transaction History
Eventide Asset Management, LLC
- $4.71 Billion
- Q1 2025
A detailed history of Eventide Asset Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,893,437 shares of VRNA stock, worth $235 Million. This represents 3.9% of its overall portfolio holdings.
Number of Shares
2,893,437
Previous 3,132,127
7.62%
Holding current value
$235 Million
Previous $145 Million
26.3%
% of portfolio
3.9%
Previous 2.79%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$533 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$448 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$319 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$281 Million13.82% of portfolio
-
Rtw Investments, LP New York, NY2.85MShares$231 Million2.96% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.95B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...